REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/16/2026
Back to search
Official data from USPTO
FARMABIOS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
03/17/2026
Trademark type
Combined
Nice classes
5, 42
Filing date
04/21/2020
Registration date
03/16/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/16/2021
Last transaction
03/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
35
Owner location
IT
Examiner
BRADLEY, EVELYN
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "FARMABIOS" with two chevrons.
Holders and representatives
Holders
Farmabios S.p.A.
Representatives
Michael N. Mercanti LUCAS & MERCANTI, LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-inflammatory preparations; cholesterol reducers; steroids; respiratory stimulants; cardiotonic; chemotherapeutics; chemico-pharmaceutical preparations for the treatment of autoimmune disordersinflammationsasthmapsoriasiscancerdermatitis; pharmaceuticals for the treatment of autoimmune disordersinflammationsasthmapsoriasiscancer and dermatitis
Class 42
Analysis and evaluation of product development; scientific analysis in the field of pharmaceuticalsactive pharmaceutical ingredientsdrug substances; chemistry consultation; consultancy relating to pharmaceutical research and development; product development consultation; consultancy relating to industrial research in the field of active pharmaceutical ingredients and new chemical entities; technical consultancy relating to product development; design and development of industrial products in the field of active pharmaceutical ingredientsdrug substances in particular steroidshigh potent substancescannabinoidsantineoplastics; conducting of scientific feasibility studies; conducting of technical feasibility studies in the field of chemical research for the synthesis of existing and new chemical entities; chemical research; research relating to technology; development of new products for others; research and development for others with regard to new products; pharmaceutical research and development; scientific and industrial research in the field of active pharmaceutical ingredientsdrug substances in particular steroidshigh potent substancescannabinoidsantineoplastics; laboratory research in the field of chemistry; industrial analysis and research services in the field of chemistry; preparation of scientific reports; preparation of technical reports relating to chemical research for the synthesis of existing and new chemical entities; engineering feasibility studies; development of new technology for others in the field of chemicalpharmaceuticalenzymatic reactions; development of industrial processes for others in the field of chemicalpharmaceuticalenzymatic reactions; development of new industrial products for others
Publications
History of USPTO decisions and trademark events.
42 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/02/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/02/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/02/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/21/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/06/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/11/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/22/2021
FIMP
FINAL DISPOSITION PROCESSED
06/22/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/16/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/16/2021
GPNX
NOTIFICATION PROCESSED BY IB
01/10/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/29/2020
PUBO
PUBLISHED FOR OPPOSITION
12/29/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/23/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/23/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/21/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
11/21/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/21/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
11/21/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/21/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/12/2020
GNFR
FINAL REFUSAL E-MAILED
11/12/2020
CNFR
FINAL REFUSAL WRITTEN
11/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/06/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/30/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/30/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/30/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/30/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/30/2020
RFNT
REFUSAL PROCESSED BY IB
09/27/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/05/2020
RFRR
REFUSAL PROCESSED BY MPU
08/24/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/19/2020
CNRT
NON-FINAL ACTION WRITTEN
07/18/2020
DOCK
ASSIGNED TO EXAMINER
07/13/2020
MAFR
APPLICATION FILING RECEIPT MAILED
06/23/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/19/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/18/2020
Continuous trademark protection
Get notified about every new filing that threatens FARMABIOS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.